With the soon to be releasd sales update, does anybody have a weekend predictions for the Global Sales figure?
Global Sales
H1 23: US$ 5.6m
H2 23: US$ 5.5m
H1 24: US$ 6.6m
H2 24: TBA
With some new sales staff partially onboarded during this half & no regulatory uncertainty like Nov/Dec 23, I’m guessing our H2 figure is about $8m - $10m taking our full year revenue (H1+H2) to circa US$14.6 -$16.6m, or AU$22-25m.
At current Market Cap of $50m, this would put us at a very low revenue multiple of only 2x which is well below the average industry rate and rate for high growth companies. With growing revenue & a nice R&D pipeline we should be more towards 5-8x revenue.
Nova Eye Medical (EYE) Discussion, page-3178
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $53.82M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 22.0¢ | $231.2K | 989.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 91844 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 70000 | 2 |
View Market Depth
| Last trade - 14.54pm 26/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |